111 related articles for article (PubMed ID: 8806261)
1. Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Cost of eradication treatment may have been overestimated.
Waugh NR
BMJ; 1996 Sep; 313(7057):622. PubMed ID: 8806261
[No Abstract] [Full Text] [Related]
2. Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Costs will probably vary according to local data.
Pugh S
BMJ; 1996 Sep; 313(7057):622; author reply 623. PubMed ID: 8806260
[No Abstract] [Full Text] [Related]
3. Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age.
Briggs AH; Sculpher MJ; Logan RP; Aldous J; Ramsay ME; Baron JH
BMJ; 1996 May; 312(7042):1321-5. PubMed ID: 8646042
[TBL] [Abstract][Full Text] [Related]
4. Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Analysis is easier with spreadsheets than decision trees.
Hall GH; Daneshmend TK; Round AP; Ayres R
BMJ; 1996 Sep; 313(7057):622; author reply 623. PubMed ID: 8806259
[No Abstract] [Full Text] [Related]
5. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
6. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Comparison groups were not clear in study.
Tham TC; Lichtenstein DR
BMJ; 1996 Sep; 313(7057):623. PubMed ID: 8806263
[No Abstract] [Full Text] [Related]
8. Decision analysis of histamine H2-receptor antagonist maintenance therapy versus Helicobacter pylori eradication therapy: a randomised controlled trial in patients with continuing pain after duodenal ulcer.
Tavakoli M; Prach AT; Malek M; Hopwood D; Senior BW; Murray FE
Pharmacoeconomics; 1999 Oct; 16(4):355-65. PubMed ID: 10623364
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of Helicobacter pylori eradication in India: to live and let live ... expensively?
Bhatia SJ; Kulkarni SG
Indian J Gastroenterol; 1997 Nov; 16 Suppl 1():S25-8. PubMed ID: 9465500
[No Abstract] [Full Text] [Related]
10. Can eradicating H pylori prevent gastric cancer?
Walt B; Kerr G
Lancet; 1998 Mar; 351(9106):887. PubMed ID: 9525379
[No Abstract] [Full Text] [Related]
11. Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia.
Groeneveld PW; Lieu TA; Fendrick AM; Hurley LB; Ackerson LM; Levin TR; Allison JE
Am J Gastroenterol; 2001 Feb; 96(2):338-47. PubMed ID: 11232673
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project.
Harvey RF; Lane JA; Nair P; Egger M; Harvey I; Donovan J; Murray L
Aliment Pharmacol Ther; 2010 Aug; 32(3):394-400. PubMed ID: 20491744
[TBL] [Abstract][Full Text] [Related]
13. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.
Ford AC; Forman D; Bailey AG; Axon AT; Moayyedi P
Gastroenterology; 2005 Dec; 129(6):1910-7. PubMed ID: 16344059
[TBL] [Abstract][Full Text] [Related]
14. Clinical inquiries. Is therapy based on endoscopy results better than empiric therapy for dyspepsia?
Rich K; Safranek S; Malaty W
J Fam Pract; 2005 Aug; 54(8):725-6. PubMed ID: 16061065
[No Abstract] [Full Text] [Related]
15. [Cost effectiveness of the eradication of Helicobacter pylori in dyspepsia].
Barenys de Lacha M
Gastroenterol Hepatol; 1999; 22(7):364-75. PubMed ID: 10535211
[No Abstract] [Full Text] [Related]
16. Managing the uninvestigated dyspeptic patient.
Farup PG
Scand J Gastroenterol; 1999 Dec; 34(12):1169-70. PubMed ID: 10636061
[No Abstract] [Full Text] [Related]
17. New patients presenting to their GP with dyspepsia: does Helicobacter pylori eradication minimise the cost of managing these patients?
McIntyre AM; Macgregor S; Malek M; Dunbar JA; Hamley JG; Cromarty JA
Int J Clin Pract; 1997; 51(5):276-81. PubMed ID: 9489084
[TBL] [Abstract][Full Text] [Related]
18. Implications for treatment: pH, Helicobacter pylori or alternative approaches?
Chey WD
Aliment Pharmacol Ther; 2005 Mar; 21 Suppl 1():17-8, 21-4. PubMed ID: 15755271
[No Abstract] [Full Text] [Related]
19. Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses.
McColl KE; Gillen D; Dickson AS
BMJ; 1999 Aug; 319(7207):451; author reply 451-2. PubMed ID: 10445937
[No Abstract] [Full Text] [Related]
20. Cost-effectiveness of routine endoscopic biopsies for Helicobacter pylori detection in patients with non-ulcer dyspepsia.
Makris N; Crott R; Fallone CA; Bardou M; Barkun A
Gastrointest Endosc; 2003 Jul; 58(1):14-22. PubMed ID: 12838214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
